The aryl hydrocarbon receptor at the osteoimmune interface: from bone homeostasis to degenerative, metabolic, and inflammatory disorders
Abstract
The aryl hydrocarbon receptor (AhR) is a transcription factor activated by ligands, which participates in multiple environmental, microbial, and metabolic signals and plays a crucial role in maintaining homeostasis. In the past, AhR was regarded as a receptor for environmental toxins, several studies in recent years have indicated a potentially significant association between AhR and bone and joint health. This review systematically describes AhR signaling pathways (including canonical and non-canonical pathways) and its ligands, and focuses on the direct regulatory role of AhR in osteoblast and osteoclast function. Additionally, this review deeply explores the immunoregulatory role of AhR in T cells and macrophages, as well as how AhR-mediated interactions between immune cells and bone cells shape the bone immune microenvironment. In addition, this review systematically reviews the mechanisms of tryptophan metabolites as AhR ligands regulating bone metabolism through the gut-immune-bone axis, and comprehensively evaluates the pathological significance of AhR in bone and joint diseases such as osteoarthritis, osteoporosis, and rheumatoid arthritis. Finally, this review explores AhR-targeted therapeutic strategies and the challenges they face, providing a new theoretical basis and viable research directions for the targeted treatment of bone and joint diseases.
Related
- The Role of the Indole-3-Acetic Acid–Aryl Hydrocarbon Receptor Axis in Inflammation and Immune Homeostasis
- CAR-macrophage immunotherapy targeting fibroblast-like synoviocytes ameliorates inflammatory and degenerative arthritis
- Aryl hydrocarbon receptor (AhR) restrains the maintenance and acquisition of the anti-inflammatory identity of monocyte-derived macrophages.
- Astrocytic EAAT-2 Upregulation Supports Neuro-Axonal Homeostasis in Chronic Inflammatory CNS Lesions.
- Context-dependent functions of insulin, IGF, and GLP signaling in inflammatory bowel disease: linking metabolism, immunity, and intestinal homeostasis
BibTeX
@article{ren2026aryl,
title = {{The aryl hydrocarbon receptor at the osteoimmune interface: from bone homeostasis to degenerative, metabolic, and inflammatory disorders}},
author = {Dan Ren and Zeyue Zhu and Pengxing Cai and Jiquan Shen and Bo Wang and Hongliang Zhang},
journal = {Frontiers in Immunology},
year = {2026},
month = nov,
doi = {10.3389/fimmu.2026.2008416},
url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.2008416},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - The aryl hydrocarbon receptor at the osteoimmune interface: from bone homeostasis to degenerative, metabolic, and inflammatory disorders
AU - Dan Ren
AU - Zeyue Zhu
AU - Pengxing Cai
AU - Jiquan Shen
AU - Bo Wang
AU - Hongliang Zhang
PY - 2026
DA - 2026/11/12
JO - Frontiers in Immunology
DO - 10.3389/fimmu.2026.2008416
UR - https://www.frontiersin.org/articles/10.3389/fimmu.2026.2008416
AB - The aryl hydrocarbon receptor (AhR) is a transcription factor activated by ligands, which participates in multiple environmental, microbial, and metabolic signals and plays a crucial role in maintaining homeostasis. In the past, AhR was regarded as a receptor for environmental toxins, several studies in recent years have indicated a potentially significant association between AhR and bone and joint health. This review systematically describes AhR signaling pathways (including canonical and non-canonical pathways) and its ligands, and focuses on the direct regulatory role of AhR in osteoblast and osteoclast function. Additionally, this review deeply explores the immunoregulatory role of AhR in T cells and macrophages, as well as how AhR-mediated interactions between immune cells and bone cells shape the bone immune microenvironment. In addition, this review systematically reviews the mechanisms of tryptophan metabolites as AhR ligands regulating bone metabolism through the gut-immune-bone axis, and comprehensively evaluates the pathological significance of AhR in bone and joint diseases such as osteoarthritis, osteoporosis, and rheumatoid arthritis. Finally, this review explores AhR-targeted therapeutic strategies and the challenges they face, providing a new theoretical basis and viable research directions for the targeted treatment of bone and joint diseases.
SN - 1664-3224
ER -